Evidence map›Paper›PMID 34418164›Full record

ArticleXenotransplantation2021

Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation.

Kazuhiro Takeuchi, Yuichi Ariyoshi, Akira Shimizu, Yuichiro Okumura, Gabriel Cara-Fuentes, Gabriela E Garcia, Thomas Pomposelli, Hironosuke Watanabe, Lennan Boyd, Dilrukshi K Ekanayake-Alper and 5 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Current status and prospects of genetically modified porcine-to-human cardiac xenotransplantation.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  12. Progress in Porcine Kidney Transplantation to Non-Human Primates.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Tolerating CD47.Clinical and translational medicine · 2024
    Review
  19. De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Kazuhiro TakeuchiColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Yuichi AriyoshiColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Akira ShimizuDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Yuichiro OkumuraColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Gabriel Cara-FuentesDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Gabriela E GarciaDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Thomas PomposelliColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Hironosuke WatanabeColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Lennan BoydColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Dilrukshi K Ekanayake-AlperColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Dasari AmarnathColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Megan SykesColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
David H SachsColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Richard J JohnsonDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado, USA.
Kazuhiko YamadaColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA.
Columbia University · USColumbia University Irving Medical Center · USUniversity of Colorado Denver · USNippon Medical School · JP

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCRR NIH HHS S10 RR027050NIAID NIH HHS P01 AI045897NIH HHS S10 OD020056
6 · The paper itself

Abstract

backgroundNephrotic syndrome is a common complication of pig-to-baboon kidney xenotransplantation (KXTx) that adversely affects outcomes. We have reported that upregulation of CD80 and down-regulation of SMPDL-3b in glomeruli have an important role in the development of proteinuria following pig-to-baboon KXTx. Recently we found induced expression of human CD47 (hCD47) on endothelial cells and podocytes isolated from hCD47 transgenic (Tg) swine markedly reduced phagocytosis by baboon and human macrophages. These observations led us to hypothesize that transplanting hCD47 Tg porcine kidneys could overcome the incompatibility of the porcine CD47-baboon SIRPα interspecies ligand-receptor interaction and prevent the development of proteinuria following KXTx.

methodsTen baboons received pig kidneys with vascularized thymic grafts (n = 8) or intra-bone bone marrow transplants (n = 2). Baboons were divided into three groups (A, B, and C) based on the transgenic expression of hCD47 in GalT-KO pigs. Baboons in Group A received kidney grafts with expression of hCD47 restricted to glomerular cells (n = 2). Baboons in Group B received kidney grafts with high expression of hCD47 on both glomerular and tubular cells of the kidneys (n = 4). Baboons in Group C received kidney grafts with low/no glomerular expression of hCD47, and high expression of hCD47 on renal tubular cells (n = 4).

resultsConsistent with this hypothesis, GalT-KO/hCD47 kidney grafts with high expression of hCD47 on glomerular cells developed minimal proteinuria. However, high hCD47 expression in all renal cells including renal tubular cells induced an apparent destructive inflammatory response associated with upregulated thrombospondin-1. This response could be avoided by a short course of weekly anti-IL6R antibody administration, resulting in prolonged survival without proteinuria (mean 170.5 days from 47.8 days).

conclusionData showed that transgenic expression of hCD47 on glomerular cells in the GalT-KO donor kidneys can prevent xenograft nephropathy, a significant barrier for therapeutic applications of xenotransplantation. The ability to prevent nephrotic syndrome following KXTx overcomes a critical barrier for future clinical applications of KXTx.

Indexed as

CD47 AntigenGraft SurvivalAnimalsAnimals, Genetically ModifiedEndothelial CellsGraft RejectionHumansPapioProteinuriaSwineTransplantation, HeterologousCD47 AntigenCD47 protein, humanCD47kidneypodocytepreclinical modelproteinuriaxenotransplantation

Identifiers

PMID34418164
PMCPMC8957703
OpenAlexW3195743387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.